Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
CBL mutations
Description:
CBL mutations are genetic alterations in the CBL gene, which encodes an E3 ubiquitin ligase implicated in hematologic malignancies.
Primary topic:
Acute Myeloid Leukemia Research (45%)
Related topics:
Acute Myeloid Leukemia Research (45%),
Myeloproliferative Neoplasms: Diagnosis and Treatment (14%),
Protein Tyrosine Phosphatases (11%)
OpenAlex ID:
keywords/cbl-mutations
The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
2017
·
Hamid Bolouri
, Jason E Farrar
, et al.
·
Nature Medicine
·
920
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
2013
·
Raphaël Itzykson
, Olivier Kosmider
, et al.
·
Journal of Clinical Oncology
·
569
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
2010
·
A Tefferi
·
Leukemia
·
550
PDF
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
2009
·
Francis H. Grand
, Claire E. Hidalgo-Curtis
, et al.
·
Blood
·
388
Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies
2011
·
Ayalew Tefferi
, William Vainchenker
·
Journal of Clinical Oncology
·
336
How I treat juvenile myelomonocytic leukemia
2015
·
Franco Locatelli
, Charlotte M. Niemeyer
·
Blood
·
239
PDF
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations
2013
·
M Meggendorfer
, U Bacher
, et al.
·
Leukemia
·
181
Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia
2011
·
Mignon L. Loh
·
British Journal of Haematology
·
161
PDF
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
2011
·
Hideki Makishima
, Anna M. Jankowska
, et al.
·
Blood
·
157
PDF
Small-Cell Lung Cancers in Patients Who Never Smoked Cigarettes
2014
·
Anna M. Varghese
, Maureen F. Zakowski
, et al.
·
Journal of Thoracic Oncology
·
148
PDF
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia
2013
·
C Allen
, R K Hills
, et al.
·
Leukemia
·
148
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies
2015
·
E Padron
, G Garcia-Manero
, et al.
·
Blood Cancer Journal
·
144
PDF
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
2017
·
Daniel B. Lipka
, Tania Witte
, et al.
·
Nature Communications
·
143
PDF
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
2016
·
M M Patnaik
, A Tefferi
·
Blood Cancer Journal
·
138
PDF
CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes
2009
·
Carola Reindl
, Hilmar Quentmeier
, et al.
·
Clinical Cancer Research
·
123
Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis
2012
·
Fabiola Traina
, Valeria Visconte
, et al.
·
PLoS ONE
·
122
PDF
Molecular Pathways: Cbl Proteins in Tumorigenesis and Antitumor Immunity—Opportunities for Cancer Treatment
2014
·
Mariya S. Liyasova
, Ke Ma
, et al.
·
Clinical Cancer Research
·
105
The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories
2011
·
A Kohlmann
, H-U Klein
, et al.
·
Leukemia
·
102
Myelodysplastic and myeloproliferative disorders of childhood
2016
·
Henrik Hasle
·
Hematology
·
99
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features
2020
·
Giacomo Coltro
, Giada Rotunno
, et al.
·
Blood Advances
·
91
ASXL1 but Not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases
2014
·
Gandhi Damaj
, Magalie Joris
, et al.
·
PLoS ONE
·
86
PDF
Next‐generation sequencing in systemic mastocytosis: Derivation of a mutation‐augmented clinical prognostic model for survival
2016
·
Animesh Pardanani
, Terra Lasho
, et al.
·
American Journal of Hematology
·
83
PDF
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia
2017
·
Julia T Geyer
, Wayne Tam
, et al.
·
Modern Pathology
·
80
PDF
Molecular aspects of myeloproliferative neoplasms
2010
·
François Delhommeau
, Dorota Jeziorowska
, et al.
·
International Journal of Hematology
·
79
MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen
2019
·
Haris Ali
, Ibrahim Aldoss
, et al.
·
Blood Advances
·
78
PDF
Show more works
View as search
Works count:
257
Citation count:
7,335
Year
Topic
Type